News
Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules
July 7, 2010 8:35 am | by Bio-Medicine.Org | CommentsJERUSALEM, Israel , July 7, 2010 /- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement (MSA) with sanofi-aventis. According to the MSA, sanofi-aventis will...
Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
July 7, 2010 8:35 am | by Bio-Medicine.Org | CommentsNEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina http://www.reportlinker.com/p0186217/Stakeholder-Opinions-Vaccines-in...
Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
July 7, 2010 8:34 am | by Bio-Medicine.Org | CommentsNEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity http://www.reportlinker.com/p0...
Renhuang Begins Trading on NYSE Amex
July 7, 2010 8:34 am | by Bio-Medicine.Org | CommentsHARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that,...
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant
July 7, 2010 8:33 am | by Bio-Medicine.Org | CommentsSOMERVILLE, N.J. , July 7 /- Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in...
Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas
July 7, 2010 8:33 am | by Bio-Medicine.Org | CommentsCINCINNATI , July 7 /PRNewswire-USNewswire/ -- Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according...
Genetically reprogrammed HSV given systemically shrinks distant sarcomas
July 7, 2010 7:37 am | by EurekAlert | Comments(Cincinnati Children's Hospital Medical Center) Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice -- still an elusive goal when treating humans with cancer,...
Researchers demystifying complex cellular communications hubs found in sensory neurons
July 7, 2010 7:37 am | by EurekAlert | Comments(American Society for Biochemistry and Molecular Biology) It's safe to say that cilia, the hairlike appendages jutting out from the smooth surfaces of most mammalian cells, have long been misunderstood -- underestimated, even.
Frontiers in Cardiovascular Biology: July 16-19, 2010, Berlin, Germany
July 7, 2010 7:37 am | by EurekAlert | Comments(European Society of Cardiology) Frontiers in Cardiovascular Biology, the first scientific meeting ever organized by the Council on Basic Cardiovascular Science of the European Society of Cardiology, is being held in Berlin this month to provide a new European platform for the...
Draper working on inner ear drug delivery device
July 7, 2010 7:37 am | by I-Micronews | CommentsDraper Laboratory from Cambridge, MA, is developing a new implantable device that can deliver drugs right to the inner ear.
Bio2 takes $1M for orthopedic materials tech
July 7, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | CommentsWoburn medical device firm Bio2 Technologies Inc. has taken in $1.1 million in equity financing. The company makes tissue engineering scaffolds, intended for orthopedic use.
Hospital study suggests that early transfusion increases acute upper GI re-bleeding risk
July 7, 2010 7:34 am | by EurekAlert | Comments(Wiley-Blackwell) Doctors have called for an urgent review of transfusion policies after a UK-wide study of 221 hospitals found that patients admitted with acute upper gastrointestinal bleeding are more than twice as likely to suffer further bleeding if they receive a red blood...
Meridian Bioscience signs deal with DiaSorin
July 7, 2010 6:45 am | by The Associated Press | CommentsMedical test kit maker Meridian Bioscience Inc. said Wednesday it signed a royalty-based development and distribution deal with DiaSorin S.p.A. Under the deal, DiaSorin will use key Meridian technology to develop several infectious disease products for use on their Liaison automated detection...
Excelimmune lands $4.5M funding
July 7, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | CommentsWoburn-based biopharmaceutical firm Excelimmune Inc. has taken in $4.5 million of a planned $8.9 million equity financing, according to a regulatory filing. The company develops therapies using human recombinant polyclonal antibodies.
Affymetrix cuts 2Q revenue guidance
July 7, 2010 5:45 am | by The Associated Press | CommentsAffymetrix Inc., which makes genetic testing technology, said Wednesday it is cutting revenue guidance for the second quarter, citing delayed equipment purchases, budget cuts, and a weaker euro.The company now expects to report revenue between $71 million and $72 million, down from prior...
